Decision letter: An open label trial of anakinra to prevent respiratory failure in COVID-19

Autor:	Charles Dinarello
Rok vydání:	2021
Předmět:	medicine.medical_specialty Anakinra Coronavirus disease 2019 (COVID-19) Respiratory failure business.industry Medicine Open label business Intensive care medicine medicine.drug
DOI:	10.7554/elife.66125.sa1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e4370e900dca65cfb0ecb08c6647936d https://doi.org/10.7554/elife.66125.sa1 Zobrazit plný text záznamu